A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine

被引:42
作者
Delbue, S
Sotgiu, G
Fumagalli, D
Valli, M
Borghi, E
Mancuso, R
Marchioni, E
Maserati, R
Ferrante, P
机构
[1] Fdn Don C Gnocchi, Biol Lab, ONLUS, IRCCS, I-20148 Milan, Italy
[2] Univ Pavia, Policlin San Matteo, Clin Infect Dis, I-27100 Pavia, Italy
[3] Univ Milan, Dept Biomed Sci & Technol, I-20122 Milan, Italy
[4] Mondino Hosp, Dept Neurol, Pavia, Italy
[5] Policlin San Matteo, Clin Infect Dis, I-27100 Pavia, Italy
关键词
cerebrospinal fluid (CSF); JC virus; progressive muttifocal leukoencephalopathy (PML); transcriptional control region (TCR) rearrangements;
D O I
10.1080/13550280590900382
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
JC virus (JCV) is the etiological agent of progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system (CNS). During the acquired immunodeficiency syndrome (AIDS) epidemic, it was the cause of the death in up to 8% of AIDS patients. The genomic organization of JCV and, in particular, the hypervariability of the transcriptional control region (TCR), a regulatory noncoding region, are well known. Given that the TCR plays a central role in the viral replication of JCV, a crucial role in the determination of the neurotropism and in the pathogenic capabilities of the virus is also suspected. Here the authors describe a case of PML that did not respond to highly active antiretroviral therapy (HAART) therapy. There was a simultaneous presence of JCV strains with four different TCR structures in urine, peripheral blood cells, serum, and cerebrospinal fluid (CSF) samples. These data confirmed that the presence of the archetype TCR is restricted to urine, while also suggesting that the degree of the rearrangement varies and increases from the peripheral blood to CSF.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 29 条
[1]   JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: Two independent aspects of virus variation [J].
Agostini, HT ;
Ryschkewitsch, CF ;
Singer, EJ ;
Stoner, GL .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :659-664
[2]  
AMEMIYA K, 1992, J BIOL CHEM, V267, P14204
[3]   HUMAN POLYOMAVIRUS JC PROMOTER ENHANCER REARRANGEMENT PATTERNS FROM PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY BRAIN ARE UNIQUE DERIVATIVES OF A SINGLE ARCHETYPAL STRUCTURE [J].
AULT, GS ;
STONER, GL .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :1499-1507
[4]   BRAIN AND KIDNEY OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PATIENTS CONTAIN IDENTICAL REARRANGEMENTS OF THE JC VIRUS PROMOTER ENHANCER [J].
AULT, GS ;
STONER, GL .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (03) :298-304
[5]   Progressive multifocal leukoencephalopathy [J].
Berger, JR ;
Major, EO .
SEMINARS IN NEUROLOGY, 1999, 19 (02) :193-200
[6]   PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY [J].
BROOKS, BR ;
WALKER, DL .
NEUROLOGIC CLINICS, 1984, 2 (02) :299-313
[7]   Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity [J].
Daniel, AM ;
Swenson, JJ ;
Mayreddy, RPR ;
Khalili, K ;
Frisque, RJ .
VIROLOGY, 1996, 216 (01) :90-101
[8]   Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue [J].
Elsner, C ;
Dörries, K .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :789-799
[9]   PCR DETECTION OF JC VIRUS-DNA IN BRAIN-TISSUE FROM PATIENTS WITH AND WITHOUT PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY [J].
FERRANTE, P ;
CALDARELLISTEFANO, R ;
OMODEOZORINI, E ;
VAGO, L ;
BOLDORINI, R ;
COSTANZI, G .
JOURNAL OF MEDICAL VIROLOGY, 1995, 47 (03) :219-225
[10]   Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment [J].
Ferrante, P ;
Delbue, S ;
Pagani, E ;
Mancuso, R ;
Marzocchetti, A ;
Borghi, E ;
Maserati, R ;
Bestetti, A ;
Cinque, P .
JOURNAL OF NEUROVIROLOGY, 2003, 9 (Suppl 1) :42-46